Regeneron Pharmaceuticals (REGN) is the biotech jungle’s clever monkey, swinging at $730.30 (U.S. News) with a $103 billion market cap as of March 26, 2025. This Tarrytown trickster’s got Dupixent,…
Sponsored by Global Alliance Consulting* Thursday June 12, 2025 VivoPower International (Nasdaq: VVPR) 👉VVPR is TODAY’S…
Sign in to your account